# A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.

> **NCT00421720** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 164 (—)

## Conditions studied

- Analgesia
- Sedation

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT00421720
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 164 (—)
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421720, "A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00421720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*